Taveras Arthur

Taveras Arthur is listed in filings as Chief Scientific Officer at X4 Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Oct 8, 2024, including sale activity. Recent filings connect the profile to X4 Pharmaceuticals, Inc. (XFOR). The current snapshot covers public activity from Oct 8, 2024. Reported amounts are shown as $43.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.